Related Experiment Video
Updated: Oct 18, 2025

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: "Crafting" a Microenvironment That Matters
Lucia Catani1, Michele Cavo1, Francesca Palandri2
1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, Institute of Hematology "Seràgnoli", University of Bologna, 40138 Bologna, Italy.
Abstract:
Myeloproliferative Neoplasms (MPN) are acquired clonal disorders of the hematopoietic stem cells and include Essential Thrombocythemia, Polycythemia Vera and Myelofibrosis. MPN are characterized by mutations in three driver genes (JAK2, CALR and MPL) and by a state of chronic inflammation. Notably, MPN patients experience increased risk of thrombosis, disease progression, second neoplasia and evolution to acute leukemia. Extracellular vesicles (EVs) are a heterogeneous population of microparticles with a role in cell-cell communication. The EV-mediated cross-talk occurs via the trafficking of bioactive molecules such as nucleic acids, proteins, metabolites and lipids. Growing interest is focused on EVs and their potential impact on the regulation of blood cancers. Overall, EVs have been suggested to orchestrate the complex interplay between tumor cells and the microenvironment with a pivotal role in "education" and "crafting" of the microenvironment by regulating angiogenesis, coagulation, immune escape and drug resistance of tumors. This review is focused on the role of EVs in MPN. Specifically, we will provide an overview of recent findings on the involvement of EVs in MPN pathogenesis and discuss opportunities for their potential application as diagnostic and prognostic biomarkers.
Insights
Extracellular vesicles (EVs) play a key role in Myeloproliferative Neoplasms (MPN) pathogenesis by mediating cell communication. Research highlights EVs
Area of Science:
- Hematology
- Oncology
- Cell Biology
Background:
- Myeloproliferative Neoplasms (MPN) are clonal hematopoietic stem cell disorders (Essential Thrombocythemia, Polycythemia Vera, Myelofibrosis) driven by mutations in JAK2, CALR, or MPL.
- MPN are associated with chronic inflammation and increased risks of thrombosis, disease progression, secondary cancers, and acute leukemia.
- Extracellular vesicles (EVs) are key mediators of intercellular communication, transferring bioactive molecules like nucleic acids and proteins.
Purpose of the Study:
- To review the current understanding of Extracellular Vesicles (EVs) involvement in Myeloproliferative Neoplasms (MPN) pathogenesis.
- To explore the potential of EVs as diagnostic and prognostic biomarkers in MPN.
Main Methods:
- Literature review of recent findings on EVs in MPN.
- Analysis of EV-mediated cross-talk mechanisms in cancer.
- Discussion of EV roles in regulating the tumor microenvironment.
Main Results:
- EVs are implicated in orchestrating the tumor microenvironment in MPN.
- EVs influence angiogenesis, coagulation, immune escape, and drug resistance in MPN.
- EVs facilitate communication between MPN cells and their surroundings.
Conclusions:
- EVs are significantly involved in the pathogenesis of Myeloproliferative Neoplasms.
- EVs hold promise as potential biomarkers for diagnosing and predicting outcomes in MPN patients.
- Further research into EV function could lead to novel therapeutic strategies for MPN.
More Related Videos
12:18LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
07:03Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
The Tumor Microenvironment
Differentiation of Common Myeloid Progenitor Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Hematopoietic Stem Cells
Mesenchymal Stem Cells